Cerebral hemorrhagic complications of thrombolytic therapy

Progress in Cardiovascular Diseases

Volumn 42, Issue 3, 1999, Pages 217-233

  Patel, S C ^a   Mody, A ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DEEP VEIN THROMBOSIS; DRUG EFFECT; DRUG MECHANISM; FIBRINOLYTIC THERAPY; HUMAN; MIDDLE CEREBRAL ARTERY; REVIEW; STROKE; THROMBOEMBOLISM;

EID: 0032752453     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0033-0620(99)70004-6     Document Type: Article

References (71)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group Tissue plasminogen activator for acute ischemic stroke N Engl J Med 333 1995 1580 1587
2. WS Tillett RL. Garner The fibrinolytic activity of hemolytic streptococci J Exp Med 58 1933 485 502
3. JS Malpas M Murphy Diseases of the blood PJ Kumar ML Clark Clinical Medicine. 1998 Bailliere Tindall London 333 336
4. VJ Marder S Sherry Thrombolytic therapy: Current status N Engl J Med 318 1988 1512 1520
5. WR Bell Thrombolytic therapy: Agents, indications, and laboratory monitoring Med Clin North Am 78 1994 745 764
6. J Cairns Coronary thrombolysis Can J Cardiol 9 1993 483 484
7. J Loscalzo Structural and kinetic comparison of recombinant human single chain and two chain human extrinsic plasminogen activator J Clin Invest 82 1988 1391 1397
8. MD Malone B Locke AJ Comerota Clinical applications of thrombolytic therapy for arterial and graft occlusion Surg Clin North Am 78 1998 647 673
9. JRB Williams The fibrinolytic activity of the urine J Exp Pathol 32 1951 530 537
10. B Ratzkin SG Lee WJ Schrenk Expression in E. Coli of biologically active enzyme by a DNA sequence coding for human plasminogen activator urokinase Proc Natl Acad Sci USA 78 1981 3313 3317
11. SS Husain V Gurewich B Lipinski Purification and partial characterization of single chain high molecular weight from of urokinase for human urine Arch Biochem Biophys 220 1983 31 38
12. GJ del Zoppo Antithrombotic therapy of acute stroke: Thrombolytic agents Thrombosis and Haemostasis 78 1997 183 190
13. NJ Beauchamp RN Bryan Acute cerebral ischemic infarction: A pathophysiologic review and radiologic perspective AJR 171 1998 73 84
14. JC Baron R von Kummer GJ del Zoppo Treatment of acute ischemic stroke. Challenging the Concept of a Rigid and Universal Time Window Stroke 26 1995 2219 2221
15. MD Ginsberg The concept of the therapeutic window: A synthesis of critical issues 19th Princetown Stroke Conference MA Moskowitz LR Caplan Cerebrovascular disease. 1995 Butterworth Heinemann Newton 331 352
16. AJ Furlan R Higashida L Wechsler PROACT II Investigators PROACT II: Recombinant prourokinase (r-ProUK) in acute cerebral thromboembolism: Initial trial results-the PROACT II Investigators Presented at the 24th American Heart Association International Conference on Stroke and Cerebral Circulation in Nashville, Tennessee February 4-6, 1999
17. J Grotta t-PA-the best current option for most patients N Engl J Med 352 1998 10 14
18. J Lodder B Krijne-Kubat J Broekman Cerebral hemorrhagic infarction at autopsy: Cardiac embolic cause and the relationship to the cause of death Stroke 17 1986 626 629
19. RD Adams HM Vander Eecken Vascular diseases of the brain Ann Rev Med 4 1953 213 253
20. L Jorgensen A Torvik Ischemic cerebrovascular disease in an autopsy series Part 2 J Neurol Sci 3 1969 285 320
21. M Hill Stroke treatment: Time is brain Stroke 352 1998 10 14
22. J Ogata C Yutani M Imakita H Ishibashi-Ueda Hemorrhagic infarct of brain without a re-opening of the occluded arteries in cardioembolic stroke Stroke 20 1989 876 883
23. Y Okada T Tamaguchi K Minematsu Hemorrhagic Transformation in cerebral embolism Stroke 20 1989 598 603
24. J Wardlaw CP Warlow Thrombolysis in acute ischemic stroke: Does it work? Stroke 23 1992 1826 1839
25. OR Horing W Dondorf AX Agnoli Hemorrhagic Cerebral infarction: A prospective study Stroke 17 1986 179 185
26. W Hacke M Kaste D Toni Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS) JAMA 274 1995 1017 1025
27. W Hacke M Kaste C Fieschi R von Kummer Randomized double-blind placebo controlled trial of thrombolytic therapy with intravenous altephase in acute ischemic stroke (ECASS II) Lancet 352 1998 1245 1251
28. P Trouillas N Nighoghossian L Derex Thrombolysis with intravenous rt-PA in a series of 100 cases of acute carotid territory stroke Stroke 29 1998 2529 2540
29. Multicenter Acute Stroke Trial—Italy (MAST-1) Study Group Randomized controlled trial of streptokinase, aspirin and combination of both in treatment of acute ischemic stroke Lancet 346 1995 1509 1514
30. Multicenter Acute Stroke Trial—Europe Study Group Thrombolytic therapy with streptokinase in acute ischemic stroke N Engl J Med 335 1996 145 150
31. GA Donnan SM Davis B Chambers Streptokinase for acute ischemic stroke with relationship to time of administration JAMA 276 1996 961 966
32. Zeumer HJ Freitag F Zanella Local intra-arterial fibrinolytic therapy in patients with stroke: Eurokinase versus recombinant tissue plasminogen activator (rt-PA) Neuroradiology 35 1993 159 162
33. GJ del Zoppo RT Higashida AJ Furlan PROACT Investigators: PROACT: A phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke Stroke 29 1997 4 11
34. F Gonner L Remonda H Mattel Local intra-arterial thrombolysis in acute ischemic stroke Stroke 29 1998 1894 1900
35. GJ del Zoppo Local intra-arterial fibrinolytic therapy Stroke 19 1988 307 313
36. J Theron P Courtheoux A Casasco Local intraarterial fibrinolysis in the carotid territory AJNR 10 1989 753 765
37. E Mori M Tabuchi T Yoshida A Yamadori Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery Stroke 19 1988 802 812
38. R Von Kummer L Bozzo S Bashanello C Manelfe for the ECASS Group Extent of ischemic brain edema and the response to plasminogen activator in acute hemispheric stroke Stroke 28 1997 270
39. The NINDS t-PA Stroke Study Group Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke Stroke 28 1997 2109 2118
40. The NINDS rt-PA Stroke Study Group Generalized efficacy of t-PA for acute stroke: Subgroup analysis of the NNDS t-PA Stroke Trial Stroke 28 1997 2119 2125
41. R von Kummer KL Allen R Holle Acute stroke: Usefulness of early CT findings before thrombolytic therapy Radiology 205 1997 327 333
42. GJ del Zoppo K Poeck MS Pessin Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke Ann Neurol 32 1992 78 86
43. SM Wolpert H Bruckmann R Greenlee Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator AJNR 14 1993 3 13
44. Guppo Italino per lo Studio della Sopravivenza Neu'Infarto Miocardico (GISSI) Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction Lancet 1 1986 397 402
45. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group Randomized trial of IV streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction Lancet 1 1988 349 360
46. Van de Werff AER Arnold for the ECASS for recombinant tissue-type plasminogen activator Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction Br Med J 297 1988 1329 1374
47. RG Wilcox CG Olsson AM Skane Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian study of early thrombolysis (ASSET) Lancet I 1988 525 530
48. AIMS Trial Study Group Effect of Intravenous APSAC on Mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial Lancet I 1988 545 549
49. 2 Gruppo Italiano pre lo studio della Sofravuivenza nell' Infarto Miocardio GISSI A factorial randomizes trial of Anistreplase versus Streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction Lancet 336 1990 65 71
50. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group ISIS-3. A randomized comparison of streptokinase versus tissue plasminogen activator versus anisreplase and of aspirin plus heparin versus aspirin alone among 41299 cases of suspected acute myocardial infarction Lancet 339 1992 753 770
51. The GUSTO Investigators (The global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries) An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction N Eng J Med 329 1993 673 682
52. JH Gurwitz JM Gore RJ Goldberg Risk for intracranial hemorrhage after tissue plasminogen activator treatment for acute myocardial infarction Ann Intern Med 129 1998 597 604
53. Timi Study Group Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in MI phase II trial N Eng J Med 320 1989 618 627
54. CS Kase MS Pessin JA Zinni Intracranial hemorrhage after coronary thrombolysis with tissue plasminogen activator Am J Med 92 1992 384 390
55. DE Levy TG Brott EC Haley Factors related to intracranial hematoma formation in patients receiving tissue-type plasminogen activator for acute ischemic stroke Stroke 25 1994 291 297
56. UR Blackman RD Sautler HN Wagner Urokinase pulmonary embolism trial phase 1 results JAMA 214 1970 2163 2172
57. W Bell JR Blackman W DeGrot Urokinase streptokinase embolism trial phase 2 results JAMA 229 1974 1606 1613
58. SZ Goldhaber CM Kessler JA Heti Recombinant tissue plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism. A randomized controlled multicenter trial J Am Coll Cardiol 20 1992 24 30
59. G Meyer H Sors B Charbonner Effects of intravenous urokinase versus altephase on total pulmonary resistance in acute massive pulmonary embolism. A European multicenter double blind trial J Am Col Cardiol 19 1992 239 245
60. SZ Goldhaber J Heit GVRK Sharma Randomized controlled trial of recombinant tissue plasminogen activator versus urokinase in treatment of acute pulmonary embolism Lancet 2 1988 293 298
61. J Dalen Thrombolytic therapy for pulmonary embolism. Is it effective? Is it safe? When is it indicated? Arch Intern Med 157 1997 2250 2256
62. Working Party on Thrombolysis in the Management of Limb Ischemia Thrombolysis in the management of lower limb peripheral arterial occlusion—A consensus document Am J Cardiol 81 1998 207 218
63. DC Berridge GS Niakin BR Hopkinson Local low dose intra-arterial thrombolytic therapy, the risk of major stroke and hemorrhage Br J Surg 76 1989 1230 1232
64. The STILE Investigators Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity. The STILE Trial Am Surg 220 1994 251 268
65. K Ouziel FJ Veith AA Sasqhara for the TOPAS Investigators Thrombolysis or peripheral arterial surgery (TOPAS): Phase 1 results J Vasc Surg 2 1996 64 75
66. VJ Marder S Sherry Thrombolytic therapy: Current status N Eng J Med 318 1988 1585 1594
67. HP Adams TG Brott AJ Furlan Guidelines for thrombolytic therapy for acute stroke: A supplement to the guidelines for the management of patients with acute ischemic stroke Stroke 27 1996 1711 1718
68. EFM Wijdicks CR Jack Intracerebral hemorrhage after fibrinolytic therapy for acute myocardial infarction Stroke 24 1993 554 557
69. JP Uglietta CM O'Connor OB Boyko H Aldrich CT patterns of intracranial hemorrhage complicating thrombolytic therapy for acute myocardial infarction Radiology 181 1991 555 559
70. JM Pfieger EP Hardee CF Contant AL Haymal Sensitivity and specificity of fluid-blood levels for coagulopathy in acute intracerebral hematomas AJNR 15 1994 217 223
71. DP de Bono RS More Prevention and management of bleeding complications after thrombolysis. International J Cardiol 38 1993 1 6